Cargando…
Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency: description of a new mutation, R384X
CASE DESCRIPTION: It is presented the phenotype of a new compound heterozygous mutation of the genes R384X and Q356X encoding the enzyme of 11-beta-hydroxylase CLINICAL FINDINGS: Severe virilization, peripheral hypertension, and early puberty. TREATMENT AND OUTCOME: Managed with hormone replacement...
Autores principales: | Matallana-Rhoades, Audrey Mary, Corredor-Castro, Juan David, Bonilla-Escobar, Francisco Javier, Mecias-Cruz, Bony Valentina, Mejia de Beldjena, Liliana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Universidad del Valle
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5091277/ https://www.ncbi.nlm.nih.gov/pubmed/27821898 |
Ejemplares similares
-
Testicular Adrenal Rest Tumor in 11-Beta-Hydroxylase Deficiency Driven Congenital Adrenal Hyperplasia
por: Kaynar, Mehmet, et al.
Publicado: (2014) -
Congenital adrenal hyperplasia due to 11-Beta-hydroxylase deficiency in a Tunisian family
por: Elfekih, Hamza, et al.
Publicado: (2020) -
Treatment and Outcome of Congenital Adrenal Hyperplasia: 21-Hydroxylase Deficiency
por: Lee, Peter A., et al.
Publicado: (2010) -
The Complexities in Genotyping of Congenital Adrenal Hyperplasia: 21-Hydroxylase Deficiency
por: Pignatelli, Duarte, et al.
Publicado: (2019) -
Height augmentation in 11β-hydroxylase deficiency congenital adrenal hyperplasia
por: Nour, Munier A, et al.
Publicado: (2015)